Patent ductus arteriosus screening

Revision as of 14:18, 4 February 2020 by Ramyar (talk | contribs) (Created page with "__NOTOC__ {{Patent ductus arteriosus}} {{CMG}}; {{AE}} {{RG}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR Acco...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Patent Ductus Arteriosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Patent Ductus Arteriosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Treatment

Medical Therapy

Preterm Infants
Term and Older Children

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Patent ductus arteriosus screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Patent ductus arteriosus screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Patent ductus arteriosus screening

CDC on Patent ductus arteriosus screening

Patent ductus arteriosus screening in the news

Blogs on Patent ductus arteriosus screening

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Patent ductus arteriosus screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

References

Template:WH Template:WS